Long-term efficacy of botulinum a toxin for blepharospasm and hemifacial spasm

Canadian Journal of Neurological Sciences

Volumn 37, Issue 5, 2010, Pages 631-636

  Gill, Harmeet S ^a   Kraft, Stephen P ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; BLEPHAROSPASM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; HEMIFACIAL SPASM; HUMAN; LINEAR REGRESSION ANALYSIS; LONG TERM CARE; LONGITUDINAL STUDY; MALE; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 77957549524     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100010817     Document Type: Article

References (28)

1. Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol. 1983;13:402-11.
2. Berardelli A, Rothwell JC, Day BL, Marsden CD. Pathophysiology of blepharospasm and oromandibular dystonia. Brain. 1985;108:593-608.
3. Adler CH, Zimmerman RA, Savino PJ, Bernardi B, Bosley TM, Sergott RC. Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography. Ann Neurol. 1992;32:502-6.
4. Elston JS. The management of blepharospasm and hemifacial spasm. J Neurol. 1992;239:5-8.
5. Taylor JDN, Kraft SP, Kazdan MS, Flanders M, Cadera W, Orton RB. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study. Can J Ophthalmol. 1991;26:133-8.
6. Carruthers J, Stubbs HA. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion. Can J Neurol Sci. 1987;14:42-5.
7. Carruthers J. Ophthalmologic use of botulinum A exotoxin. Can J Ophthalmol. 1985;20:135-41.
8. Lingua RW. Sequelae of botulinum toxin injection. Am J Ophthalmol. 1985;100:305-7.
9. Kraft SP, Lang AE. Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations. Can J Neurol Sci. 1988;15:276-80.
10. Ainsworth JR, Kraft SP. Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm. Ophthalmology. 1995;102:2036-40.
11. Dutton JJ, Buckley EG. Long-term results and complications of botulinum A toxin in treatment of blepharospasm. Ophthalmology. 1988;95(12):1529-34.
12. Vogt T, Lussi F, Paul A, Urban P. Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A. Nervenarzt. 2008;79:912-17.
13. Mauriello JA, Coniaris H, Haupt EJ. Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias. Ophthalmology. 1987;94:976-9.
14. Shorr N, Seiff SR, Kopelman J. The use of botulinum toxin in blepharospasm. Am J Ophthalmol. 1985;99:542-6.
15. Drummond GT, Hinz BJ. Botulinum toxin for blepharospasm and hemifacial spasm: stability of duration of effect and dosage over time. Can J Ophthalmol. 2001;36(7):398-403.
16. Hsiung GYR, Das SK, Ranawaya R, Lafontaine AL, Suchowersky O. Long-term efficiacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Movement Disord. 2002;17(6):1288-93.
17. Calace P, Cortese G, Piscopo R, Della Volpe G, Gagliardi V, Magli A, et al. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Eur J Ophthalmol. 2003;13(4):331-6.
18. Nussgens Z, Roggenkamper P. Long-term treatment of blepharospasm with botulinum toxin type A. Ger J Ophthalmol. 1995;4:363-7.
19. Jitpimolmard S, Tiamkao S, Laopaiboon M. Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry. 1998;64:751-7.
20. Flanders M, Chin D, Boghen D. Botulinum toxin: preferred treatment for hemifacial spasm. Eur Neurol. 1993;33(4):316-19.
21. Defazio G, Abbruzzese G, Girlanda P, Vacca L, Curra A, De Salvia R, et al. Botulinum toxin A treatment for primary hemifacial spasm. A 10-year multicenter study. Arch Neurol. 2002;59:418-20.
22. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology. 1990;40:277-80.
23. Tan EK, Jankovic J. Bilateral hemifacial spasm: a report of five cases and a literature review. Movement Disord. 1999;14(2):345-9.
24. Bonner PH, Friedli AF, Baker RS. Botulinum A toxin stimulates neurite branching in nerve-muscle cocultures. Dev Brain Res. 1994;79:39-46.
25. Kessler KR, Benecke R. Botulinum toxin: from poison to remedy. Neurotoxicology. 1997;18(3):761-70.
26. Borodic G, Johnson E, Goodenough M, Schantz E. Botulinum toxin therapy, immunological resistance, and problems with available materials. Neurology. 1996;46:26-30.
27. Cakmur R, Ozturk V, Uzunel F, Donmez B, Idiman F. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neurol. 2002;249:64-8.
28. Jankovic J. Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening. J Neurol Neurosurg Psychiatry. 1996;60(6):704.